Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Dmochowski

Showing results (81-90 of 184) with videos related to

Pageof 19
Sort By:
Urology|February 8, 2006
Multicenter phase III trial studying trospium chloride in patients with overactive bladderDelbert Rudy, Kevin Cline, Richard Harris, et al.
BJU International|February 14, 2006
Time to onset of improvement in symptoms of overactive bladder using antimuscarinic treatmentDelbert Rudy, Kevin Cline, Richard Harris, et al.
BJU International|June 8, 2007
The clinical efficacy of tolterodine extended-release is maintained for 24 h in patients with overactive bladderRoger Dmochowski, Karl Kreder, Scott MacDiarmid, et al.
Expert Opinion on Pharmacotherapy|September 20, 2022
Vibegron for the treatment of overactive bladder: a comprehensive updateStephanie Gleicher, Elisabeth M Sebesta, W Stuart Reynolds, et al.
Urology|January 10, 2025
Reply to Letter to the Editor on "Social Vulnerability Is Associated With Worse Urinary Incontinence and Quality of Life in Women"William Furuyama, Melissa Kaufman, Roger Dmochowski, et al.
Current Urology Reports|August 6, 2013
Mirabegron for male lower urinary tract symptomsOscar Suarez, David Osborn, Melissa Kaufman, et al.
Urology|August 27, 2013
Obesity and female stress urinary incontinenceDavid James Osborn, Matthew Strain, Alex Gomelsky, et al.
Urology|November 24, 2024
Social Vulnerability Is Associated With Worse Urinary Incontinence and Quality of Life in WomenWilliam Furuyama, Melissa Kaufman, Roger Dmochowski, et al.
Neurourology and Urodynamics|February 14, 2016
Do we understand how botulinum toxin works and have we optimized the way it is administered to the bladder? ICI-RS 2014Apostolos Apostolidis, Mohammad S Rahnama'i, Christopher Fry, et al.
European Urology|November 14, 2006
Efficacy and tolerability of tolterodine extended release in male and female patients with overactive bladderRoger Dmochowski, Paul Abrams, Daniela Marschall-Kehrel, et al.
Pageof 19

Showing results (81-90 of 184) with videos related to

Sort By:
Pageof 19
Urology|February 8, 2006
Multicenter phase III trial studying trospium chloride in patients with overactive bladderDelbert Rudy, Kevin Cline, Richard Harris, et al.
BJU International|February 14, 2006
Time to onset of improvement in symptoms of overactive bladder using antimuscarinic treatmentDelbert Rudy, Kevin Cline, Richard Harris, et al.
BJU International|June 8, 2007
The clinical efficacy of tolterodine extended-release is maintained for 24 h in patients with overactive bladderRoger Dmochowski, Karl Kreder, Scott MacDiarmid, et al.
Expert Opinion on Pharmacotherapy|September 20, 2022
Vibegron for the treatment of overactive bladder: a comprehensive updateStephanie Gleicher, Elisabeth M Sebesta, W Stuart Reynolds, et al.
Urology|January 10, 2025
Reply to Letter to the Editor on "Social Vulnerability Is Associated With Worse Urinary Incontinence and Quality of Life in Women"William Furuyama, Melissa Kaufman, Roger Dmochowski, et al.
Current Urology Reports|August 6, 2013
Mirabegron for male lower urinary tract symptomsOscar Suarez, David Osborn, Melissa Kaufman, et al.
Urology|August 27, 2013
Obesity and female stress urinary incontinenceDavid James Osborn, Matthew Strain, Alex Gomelsky, et al.
Urology|November 24, 2024
Social Vulnerability Is Associated With Worse Urinary Incontinence and Quality of Life in WomenWilliam Furuyama, Melissa Kaufman, Roger Dmochowski, et al.
Neurourology and Urodynamics|February 14, 2016
Do we understand how botulinum toxin works and have we optimized the way it is administered to the bladder? ICI-RS 2014Apostolos Apostolidis, Mohammad S Rahnama'i, Christopher Fry, et al.
European Urology|November 14, 2006
Efficacy and tolerability of tolterodine extended release in male and female patients with overactive bladderRoger Dmochowski, Paul Abrams, Daniela Marschall-Kehrel, et al.
Pageof 19